This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed price contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a completion date of June 3, 2025. This is a non-set-aside delivery order contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has a ceiling value of $7,242.15 and runs through October 8, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,740.00, is for the delivery of 4,567,965,328 units of the drug BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a registered vendor in SAM.gov. The contract is not...
This is a Firm Fixed Price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $50,960.00 and a period of performance through March 24, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $7,242.15 to provide BRUKINSA 80 MG CAPSULE 120S medication. The contract has a period of performance through April 29, 2024. This delivery order is a child contract under an indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract is a delivery order with a firm fixed price of $6,370.00 and a completion date of April 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has a ceiling value of $6,370.00 and a period of performance through February 26, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $12,740.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $19,110.00 and a completion date of June 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract is not set-aside and is open to full and open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,568,105,568 units of the drug BRUKINSA 80 MG CAPSULE 120S, with a ceiling value of $6,370.00. The contract has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...